Living With C diff: Juggling a Newborn, a Surprising Diagnosis, and a Difficult Year
September 13th 2023In our continuing series with members of the Peggy Lillis Foundation, here is an opportunity to hear about people’s experiences, lessons learned, and the new treatments that can lead to hope and not the hopelessness people have been living with during their ordeals.
CDC ACIP Votes to Recommend Updated mRNA COVID-19 Vaccines
September 12th 2023The federal agency’s Advisory Committee on Immunization Practices (ACIP) recommendation was to authorize and approve the updated 2023-2024 (monovalent, XBB containing) COVID-19 vaccines for persons 6 months of age and older.
CDC Publishes 2 Reports on Hepatitis Incidence Rates and Progress Towards 2025 Goals
September 10th 2023The federal agency’s reports shows decreases in both hepatitis A and B, but hepatitis C saw a significant increase during 2021. However, the investigators note the pandemic may have impacted statistics and progress towards goals.
This Week's Biggest News Stories
September 9th 2023Learn more about how hospitalizations due to alcohol-associated hepatitis increased during the pandemic; the next installment in our ongoing RSV series; developing a product for a potential functional cure of hepatitis B; and an investigational vaccine being studied in a challenge trial for norovirus.
Bacterial Infections in People With Cystic Fibrosis: A Race Against Time
September 7th 2023Patient advocate Ella Balasa has been living with cystic fibrosis her whole life. She experienced a multidrug resistant infection in 2019 and is speaking about her personal experiences at the World AMR Congress reminding people about the need to improve the antibiotic development paradigm.
CDC Issues Health Advisory Alert After Increases in RSV Activity
September 6th 2023Due to increased RSV activity in the southeast United States, the CDC has issued an official Health Alert Network Health Advisory. The federal agency recommends clinicians prepare to implement recently FDA-approved prevention methods.
EMA Recommends Updated Pfizer-BioNTech COVID-19 Vaccine
September 2nd 2023The European Medicines Agency (EMA) based its decision on preclinical data showing that the Omicron XBB.1.5-adapted monovalent COVID-19 vaccine generates an improved response against multiple XBB-related sublineages, including XBB15, XBB116, XBB23, and EG51.